Correlation Between Opus Genetics, and Upstream Bio,

Can any of the company-specific risk be diversified away by investing in both Opus Genetics, and Upstream Bio, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Opus Genetics, and Upstream Bio, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Opus Genetics, and Upstream Bio,, you can compare the effects of market volatilities on Opus Genetics, and Upstream Bio, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Opus Genetics, with a short position of Upstream Bio,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Opus Genetics, and Upstream Bio,.

Diversification Opportunities for Opus Genetics, and Upstream Bio,

0.22

Correlation Coefficient

Opus Genetics,  Upstream Bio,

Modest diversification

The 3 months correlation between Opus and Upstream is 0.22. Overlapping area represents the amount of risk that can be diversified away by holding Opus Genetics, and Upstream Bio, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Upstream Bio, and Opus Genetics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Opus Genetics, are associated (or correlated) with Upstream Bio,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Upstream Bio, has no effect on the direction of Opus Genetics, i.e., Opus Genetics, and Upstream Bio, go up and down completely randomly.

Pair Corralation between Opus Genetics, and Upstream Bio,

Considering the 90-day investment horizon Opus Genetics, is expected to under-perform the Upstream Bio,. But the stock apears to be less risky and, when comparing its historical volatility, Opus Genetics, is 1.23 times less risky than Upstream Bio,. The stock trades about -0.02 of its potential returns per unit of risk. The Upstream Bio, is currently generating about 0.06 of returns per unit of risk over similar time horizon. If you would invest  1,700  in Upstream Bio, on September 28, 2024 and sell it today you would earn a total of  200.00  from holding Upstream Bio, or generate 11.76% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	87.3%
Values	Daily Returns

Opus Genetics,  vs.  Upstream Bio,

Opus Genetics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Opus Genetics, has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest weak performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Upstream Bio,

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Upstream Bio, are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Upstream Bio, sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Opus Genetics, and Upstream Bio,

The main advantage of trading using opposite Opus Genetics, and Upstream Bio, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Opus Genetics, position performs unexpectedly, Upstream Bio, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Upstream Bio, will offset losses from the drop in Upstream Bio,'s long position.

The idea behind Opus Genetics, and Upstream Bio, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Aroon Oscillator module to analyze current equity momentum using Aroon Oscillator and other momentum ratios.